Breast Cancer News and Research

Latest Breast Cancer News and Research

Thermo Fisher Scientific and Newman-Lakka Institute collaborate to develop new diagnostic approaches for personalized cancer treatment

Thermo Fisher Scientific and Newman-Lakka Institute collaborate to develop new diagnostic approaches for personalized cancer treatment

Rural women with breast cancer less likely to receive radiation therapy after lumpectomy

Rural women with breast cancer less likely to receive radiation therapy after lumpectomy

Investigators uncover connection between tumor metabolic process and progression of kidney cancer

Investigators uncover connection between tumor metabolic process and progression of kidney cancer

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

GE Healthcare to acquire certain Mammography assets of Rayence

GE Healthcare to acquire certain Mammography assets of Rayence

EORTC starts phase 2 trial in elderly patients with HER-2 positive metastatic breast cancer

EORTC starts phase 2 trial in elderly patients with HER-2 positive metastatic breast cancer

Grassroots tactics being used in health law's roll-out

Grassroots tactics being used in health law's roll-out

AACE applauds the American Medical Association for recognizing obesity as disease state

AACE applauds the American Medical Association for recognizing obesity as disease state

Stress exposure may be associated with increased risk of aggressive breast cancer

Stress exposure may be associated with increased risk of aggressive breast cancer

Diet, lifestyle and environment attribute to the cause of majority of cancer cases

Diet, lifestyle and environment attribute to the cause of majority of cancer cases

Signaling pathway correlates with EGFR status and poor survival in breast cancer patients

Signaling pathway correlates with EGFR status and poor survival in breast cancer patients

UCSC experts awarded $3.5M NIH grant to develop cancer genomics tools

UCSC experts awarded $3.5M NIH grant to develop cancer genomics tools

Genomic instability in new molecular pathway may predict worse outcomes in breast cancer patients

Genomic instability in new molecular pathway may predict worse outcomes in breast cancer patients

Targeting SALL4 protein with druglike molecules could halt tumor growth, say researchers

Targeting SALL4 protein with druglike molecules could halt tumor growth, say researchers

Medical experts spot cancerous abnormalities on medical images in a single glance

Medical experts spot cancerous abnormalities on medical images in a single glance

Health exchanges: Choice of plans will vary sharply from state to state

Health exchanges: Choice of plans will vary sharply from state to state

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

In unanimous decision, Supreme Court justices rule genes can't be patented

In unanimous decision, Supreme Court justices rule genes can't be patented

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.